A Phase 1 study of D3S-003 as Monotherapy in Participants with Advanced Solid Tumors with a KRAS p.G12D Mutation.

The requested reference [239a29fd76ca809bf965b3d792c085885bdcba84] no longer exists in our database. It has been replaced by the current reference: [a4dd36e27fd9b54c47efce534c268531752111d2]

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 32d6fc7945f837b74db3f9925df4dba5232a5d01
First added on: Oct 10, 2026